Literature DB >> 7582982

Rates of thrombin acylation and deacylation upon reaction with low molecular weight acylating agents, carbamylating agents and carbonylating agents.

A D Brown1, J C Powers.   

Abstract

Acylated derivatives of thrombin have been made using low molecular weight acylating agents, carbamylating agents and carbonylating agents. The compounds used to acylate the active site serine include isatoic anhydrides, benzoxazinones, benzylisocyanate, N-(benzylcarbonyloxy)succinimide and p-(dimethylamino)benzoylimidazolide. The rates of acylation and deacylation were determined. The best overall inhibitors of thrombin are 2-ethoxy-4H-3,1-benzoxazin-4-one, isatoic anhydride and tert-butyl-2,4-dioxo-2H-3,1-benzoxazine-1(4H)-acetate, which have k2/Ki values of 52,700 M-1s-1, 48,900 M-1s-1 and 5400 M-1s-1, respectively. The carbamyl derivative of thrombin formed with benzylisocyanate had the slowest rate of deacylation (2.3 x 10(-7) s-1), while the ester derivative formed with 2-(N,N-dimethylamino)methylimino-4H-3,1-benzoxazin-4-one had the fastest rate of deacylation (1.9 x 10(-4) s-1).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582982     DOI: 10.1016/0968-0896(95)00099-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  2-Amino- and 2-alkylthio-4H-3,1-benzothiazin-4-ones: synthesis, interconversion and enzyme inhibitory activities.

Authors:  Hans-Georg Häcker; Florian Grundmann; Friederike Lohr; Philipp A Ottersbach; Jing Zhou; Gregor Schnakenburg; Michael Gütschow
Journal:  Molecules       Date:  2009-01-14       Impact factor: 4.411

2.  Preparation of novel (Z)-4-ylidenebenzo[b]furo[3,2-d][1,3]oxazines and their biological activity.

Authors:  Yukako Tabuchi; Yuko Ando; Hidemi Kanemura; Ikuo Kawasaki; Takahiro Ohishi; Masao Koida; Ryo Fukuyama; Hiromichi Nakamuta; Shunsaku Ohta; Kiyoharu Nishide; Yoshitaka Ohishi
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.